{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Dietary supplements", "Herbal medicine", "Insulin resistance", "Nonalcoholic fatty liver disease", "Thymus plant", "Traditional medicine", "Zataria multiflora"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30477827", "DateCompleted": {"Year": "2019", "Month": "03", "Day": "04"}, "DateRevised": {"Year": "2019", "Month": "03", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "09", "Day": "17"}], "Language": ["eng"], "ELocationID": ["10.1016/j.ctim.2018.09.010", "S0965-2299(18)30712-X"], "Journal": {"ISSN": "1873-6963", "JournalIssue": {"Volume": "41", "PubDate": {"Year": "2018", "Month": "Dec"}}, "Title": "Complementary therapies in medicine", "ISOAbbreviation": "Complement Ther Med"}, "ArticleTitle": "The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial.", "Pagination": {"StartPage": "118", "EndPage": "123", "MedlinePgn": "118-123"}, "Abstract": {"AbstractText": ["The aim of the study is to evaluate the effects of Zataria multiflora Boiss. (Shirazi thyme) (ZM) supplementation on nonalcoholic fatty liver disease (NAFLD) and related insulin resistance (IR).", "In this randomized double-blind placebo-controlled clinical trial, 85 patients with NAFLD were administered either 700\u2009mg ZM powder or placebo twice daily for 12 weeks. All patients were advised to follow the recommendations for diet modification.", "ZM supplementation resulted in a significant reduction in serum insulin level (-2.72\u2009\u00b1\u20090.80 vs -0.67\u2009\u00b1\u20090.90, P<sub>=</sub>0.030), insulin resistance (-0.80\u2009\u00b1\u20090.22 vs 0.06\u2009\u00b1\u20090.22, P<sub>=</sub>0.023), systolic (-3.44\u2009\u00b1\u20091.05 vs 1.03\u2009\u00b1\u20090.98, P<sub>=</sub> 0.002) and diastolic (-2.33\u2009\u00b1\u20090.77 vs 0.26\u2009\u00b1\u20090.63, P<sub>=</sub> 0.009) blood pressure in patients with NAFLD in comparison with the placebo group. There was no significant difference between two groups regarding serum levels of alanine aminotransferase (ALT), high sensitive C-reactive protein (hs-CRP), Tumor necrosis factor-\u03b1 (TNF-\u03b1), grade of fatty liver in ultrasonography, lipid profiles, and other outcomes.", "ZM supplementation with daily dose of 1400\u2009mg for 12 weeks improved insulin resistance in patients with NAFLD. Further studies with longer duration and larger sample size are recommended."], "CopyrightInformation": "Copyright \u00a9 2018 Elsevier Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Persian Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Zamani", "ForeName": "Nasrindokht", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Endocrine and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: shams@sums.ac.ir."}], "LastName": "Shams", "ForeName": "Mesbah", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: mnimruzi@yahoo.com."}], "LastName": "Nimrouzi", "ForeName": "Majid", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Processing Research Center, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Phytopharmaceuticals (Traditional Pharmacy), School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Zarshenas", "ForeName": "Mohammad Mehdi", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Abolhasani Foroughi", "ForeName": "Amin", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Fallahzadeh Abarghooei", "ForeName": "Ebrahim", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Gasteroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Fattahi", "ForeName": "Mohammad Reza", "Initials": "MR"}], "PublicationTypeList": ["Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "Scotland", "MedlineTA": "Complement Ther Med", "NlmUniqueID": "9308777", "ISSNLinking": "0965-2299"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Insulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipids"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "9007-41-4", "NameOfSubstance": "C-Reactive Protein"}, {"RegistryNumber": "EC 2.6.1.2", "NameOfSubstance": "Alanine Transaminase"}], "CommentsCorrectionsList": [{"RefSource": "Complement Ther Med. 2019 Feb;42:270. doi: 10.1016/j.ctim.2018.11.008", "PMID": "30670253"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["blood"], "DescriptorName": "Alanine Transaminase"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Pressure"}, {"QualifierName": ["metabolism"], "DescriptorName": "C-Reactive Protein"}, {"QualifierName": [], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["blood"], "DescriptorName": "Insulin"}, {"QualifierName": [], "DescriptorName": "Insulin Resistance"}, {"QualifierName": ["blood"], "DescriptorName": "Lipids"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Liver"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["blood", "drug therapy"], "DescriptorName": "Non-alcoholic Fatty Liver Disease"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Thymus Plant"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "7", "Day": "20"}, {"Year": "2018", "Month": "9", "Day": "13"}, {"Year": "2018", "Month": "9", "Day": "14"}, {"Year": "2018", "Month": "11", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "5", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30477827", "10.1016/j.ctim.2018.09.010", "S0965-2299(18)30712-X"]}}]}